Argent Biopharma Limited Date of AGM & Closing Date of Director Nominations
September 25 2024 - 1:50AM
RNS Regulatory News
RNS Number : 5923F
Argent Biopharma Limited
25 September 2024
25
September 2024
Argent BioPharma
Ltd.
(Argent BioPharma or the Company)
Date of AGM and Closing Date
for Director Nominations
Argent BioPharma, an innovative
multidisciplinary drug discovery company within the
biopharmaceutical sector, advises that in accordance with ASX
Listing Rule 3.13.1, that the Company's Annual General Meeting is
planned to be held on Thursday, 28 November 2024.
The closing date for receipt of
nominations for persons wishing to be considered for election as a
director is, 10 October 2024. Any nominations must be received at
the Company's registered office no later than 5.00pm (WST) on 10
October 2024.
-Ends-
Authorised for release by the Company Secretary, for further
information please contact:
About Argent
BioPharma
Argent BioPharma Limited (the
"Company") (ASX: RGT; LSE:
RGT; OTCQB: RGTLF) an innovative multidisciplinary drug development
Company within the biopharmaceutical sector. The Company
focuses on multidisciplinary methods with Nanotechnology,
developing multi-target therapies for comprehensive disease
management, especially concerning the central nervous system
("CNS") and Immunology treatments.
Follow us through our social media
channels:
LinkedIn: Argent
BioPharma
Twitter: @ArgentBioPharma
Facebook: Argent
BioPharma
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NOALAMFTMTITMPI
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Nov 2023 to Nov 2024
